(Q43176072)

15 November 2017

title

Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan (English)

1 reference

15 November 2017

3

Yasushi Honda

1 reference

15 November 2017

Shu-Ling Hoshi

1

1 reference

15 November 2017

Masahide Kondo

series ordinal

2

1 reference

15 November 2017

Ichiro Okubo

series ordinal

4

1 reference

15 November 2017

language of work or name

English

0 references

publication date

21 June 2007

1 reference

15 November 2017

1 reference

15 November 2017

volume

25

1 reference

15 November 2017

issue

35

1 reference

15 November 2017

page(s)

6511-6521

1 reference

The global impact of influenza on morbidity and mortality

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Serious morbidity and mortality associated with influenza epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Epidemiological data on influenza in Asian countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Influenza vaccination in 29 countries. An update to 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Impact of influenza vaccination on seasonal mortality in the US elderly population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

7 January 2021

Influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Economic evaluation of vaccination against influenza in New Zealand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Economic evaluation of influenza vaccination. Assessment for The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Economic evaluation of strategies for the control and management of influenza in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

The economic impact of pandemic influenza in the United States: priorities for intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Antibody response to influenza vaccination in the elderly: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Policy evaluation for the subsidy for influenza vaccination in elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

[Estimation of excess mortality associated with influenza-epidemics by age and cause specific death in Japan, 1975-1999]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Pharmacoeconomic evaluation of oseltamivir as prophylaxis against influenza infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

[Costs of influenza therapy]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Additive preventive effect of influenza and pneumococcal vaccines in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Why cost-effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Antiviral therapy for influenza : a clinical and economic comparative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

The Japanese experience with vaccinating schoolchildren against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.067

10.1016/J.VACCINE.2007.05.067

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference